Writing this once so I can stop repeating it across threads. It is about oral semaglutide, and it is deliberately narrow — everything I am not confident about is marked as such.
What is actually established
Orforglipron is the more interesting oral story because it is not a peptide at all. Being a small molecule it does not need SNAC, does not need the fasting window, and has oral bioavailability in the tens of percent rather than about one.
The condition it depends on
Worth adding that the tablet is taken daily, so a missed dose costs far less than a missed weekly injection. That is a genuine advantage nobody lists.
The practical version
The practical numbers: about 1% oral bioavailability, 30 minutes fasted before food, no more than 120ml of plain water, and coffee counts as food for this purpose.
What I am not sure about
So the question, as narrowly as I can put it: whether the fasting requirement is as strict in practice as the label implies, and what people actually see when they get it wrong. Happy to be told the question itself is wrong.
— kate.chem · corrections welcome and will be edited into this post with credit